Over 100,000 people have volunteered to take part in COVID-19 vaccine trials, helping to speed up efforts to discover a safe and effective vaccine.
As testing turnaround times stretch to a week or more for some parts of the country, a group of 50 biotech companies has figured out a surveillance system with results in 12 hours.
Dr. Dan Wang, Head, Johnson & Johnson Innovation, Asia Pacific, and Dr. Sharon Chan, Head of JLABS @ Shanghai discuss its support of startups, interests in diverse disease areas, the ...
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Allovir Inc (NASDAQ: ALVR) BioLife Solutions Inc (NASDAQ: BLFS) BioSpecifics Technologies Corp. (NASDAQ: BSTC) (...
We need a new funding model for drug discovery to support the small biotech startups which develop new drugs far more cost-effectively than big pharma.
An investigator said, if the process continued smoothly, the vaccine would be available in the first half of 2021.
“The vaccine is safe. We have not observed any adverse events in any of the volunteers at our site,” said Savita Verma, principal investigator, who is leading the trial.